Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Aug 9, 2022 · 10-Q · 40 days after period end · 0001640334-22-001681
| Metric | Q2 2022 | Q2 2021 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$2.45M | -$2.25M | -$424.79K | -$798.46K |
| EPS Diluted | — | — | -$0.40 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 9, 2022 · 40 d after period end
